Stabilization of Oncostatin-M mRNA by Binding of Nucleolin to a GC-Rich Element in Its 3′UTR

Journal of Cellular Biochemistry

Volumn 117, Issue 4, 2016, Pages 988-999

  Saha, Sucharita ^a   Chakraborty, Alina ^a   Bandyopadhyay, Sumita Sengupta ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

3 UNTRANSLATED REGION; CYTOKINE; GC RICH ELEMENT; mRNA STABILITY; PHORBOL 12 MYRISTATE 13 ACETATE

Indexed keywords

CIS ACTING ELEMENT; MESSENGER RNA; NUCLEOLIN; ONCOSTATIN M; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR GCRE 1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; OSM PROTEIN, HUMAN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOPROTEIN; PROTEIN BINDING;

3' UNTRANSLATED REGION; AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; GC RICH SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REPORTER GENE; RNA STABILITY; U937 CELL LINE; WESTERN BLOTTING; BINDING SITE; CHEMISTRY; CYTOLOGY; DNA BASE COMPOSITION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MONOCYTE; PLASMID; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE COMPOSITION; BINDING SITES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; ONCOSTATIN M; PHOSPHOPROTEINS; PLASMIDS; PROTEIN BINDING; RNA STABILITY; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 84958107716     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25384     Document Type: Article

References (44)

1. Abdelmohsen K, Gorospe M,. 2012. RNA-binding protein nucleolin in disease. RNA Biol 9 (6): 799-808.
2. Amaral MC, Miles S, Kumar G, Nel AE,. 1993. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42 (MAPK)/ERK-2 in Kaposi's cells: Evidence that this pathway is important in Kaposi cell growth. J Clin Invest 92 (2): 848-857.
3. Auguste P, Guillet C, Fourcin M, Olivier C, Vezier J, Pouplard-Barthelaix A, Gascan H,. 1997. Signaling of type II Oncostatin M receptor. J Biol Chem 272 (25): 15760-15764.
4. Bandyopadhyay S, Sengupta TK, Spicer EK,. 2008. PMA induces stabilization of oncostatin M mRNA in human lymphoma U937 cells. Biochem J 410 (1): 177-186.
5. Berger CM, Gaume X, Bouvet P,. 2015. The roles of nucleolin subcellular localization in cancer. Biochimie 113: 78-85.
6. Caizergues-Ferrer M, Belenguer P, Lapeyre B, Amalric F, Wallace MO, Olson MO,. 1987. Phosphorylation of nucleolin by a nucleolar type NII protein kinase. Biochemistry 26 (24): 7876-1883.
7. Chen CY, Xu N, Shyu AB,. 1995. MRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: Different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 15 (10): 5777-5788.
8. Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, Mann M, Karin M,. 2000. Nucleolin and YB-1 are required for JNK mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 14: 1236-1248.
9. David E, Tirode F, Baud'huin M, Guihard P, Laud K, Delattre O, Heymann MF, Heymann D, Redini F, Blanchard F,. 2012. Oncostatin M is a growth factor for Ewing sarcoma. Am J Pathol 181: 1782-1795.
10. Douglas M, Goss GA, Sutherland RL, Hilton DJ, Berndt MC, Nicola NA, Begley CG,. 1997. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 14 (6): 661-669.
11. Elbjeirami WM, Donnachie EM, Burns AR, Smith CW,. 2011. Endothelium-derived GM-CSF influences expression of oncostatin M. Am J Physiol Cell Physiol 301 (4): C947-C953.
12. Ensoli F, Fiorelli V, DeCristofaro M, Santini, Muratori D, Novi A, Vannelli B, Thiele CJ, Luzi G, Aiuti F,. 1999. Inflammatory cytokines and HIV1 associated neurodegeneration: Oncostatin-M produced by mononuclear cells from HIV-1 infected individuals induces apoptosis of primary neurons. J Immunol 162 (10): 6268-6277.
13. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF, Cosman D,. 1992. The IL-6 signal transducer, gp130: An Oncostatin M receptor and affinity converter for the LIF receptor. Science 255 (5050): 1434-1437.
14. Ghisolfi-Nieto L, Joseph G, Puvion-Dutilleul F, Amalric F, Bouvet P,. 1996. Nucleolin is a sequence-specific RNA-binding protein: Characterization of targets on pre-ribosomal RNA. J Mol Biol 260 (1): 34-53.
15. Goodarzi H, Zhang S, Buss CG, Fish L, Tavazoie S, Tavazoie SF,. 2014. Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins. Nature. 513 (7517): 256-260.
16. Grant SL, Douglas AM, Goss GA, Begley CG,. 2001. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors 19 (3): 153-162.
17. Hung CY, Yang WB, Wang SA, Hsu TI, Chang WC, Hung JJ,. 2014. Nucleolin enhances internal ribosomal entry site (IRES)-mediated-translation-of Sp1 in tumorigenesis. Biochim Biophys Acta 1843 (12): 2843-2854.
18. Hutt JA, DeWille JW,. 2002. Oncostatin-M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein delta-dependent pathway. Mol Cancer Ther 1 (8): 601-610.
19. Ishimaru D, Zuraw L, Ramalingam S, Sengupta TK, Bandyopadhyay S, Reuben A, Fernandes DJ, Spicer EK,. 2010. Me chanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1). J Biol Chem 285 (35): 27182-27191.
20. Keene JD,. 2007. RNA regulons: Coordination of post-transcriptional events. Nat Rev Genet 8 (7): 533-543.
21. Kudla G, Lipinski L, Caffin F, Helwak A, Zylicz M,. 2006. High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol 4 (6): e180.
22. Lee PT, Liao PC, Chang WC, Tseng JT,. 2007. Epidermal growth factor increases the interaction between nucleolin and heterogeneous nuclear ribonucleoprotein K/poly(C) binding protein 1 complex to regulate the gastrin mRNA turnover. Mol Biol Cell 18 (12): 5004-5013.
23. Li Q, Zhu J, Sun F, Liu L, Liu X, Yue Y,. 2011. Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3. Int J Mol Med 28 (1): 101-108.
24. Loflin PT, Chen CY, Xu N, Shyu AB,. 1999. Transcriptional pulsing approaches for analysis of mRNA turnover in mammalian cells. Methods 17 (1): 11-20.
25. Mongelard F, Bouvet P,. 2010. AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. Curr Opi Mol Ther 12 (1): 107-114.
26. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA,. 2002. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26 (2): 182-190.
27. Palmqvist P, Lundberg P, Lundgren I, Hänström L, Lerner UH,. 2008. IL-1beta and TNF-alpha regulate IL-6-type cytokines in gingival fibroblasts. J Dent Res 87 (6): 558-563.
28. Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola AV, Hofmeister CC, Marcucci C, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM,. 2013. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med 210: 951e-968.
29. Pickering BF, Yu D, Van Dyke MW,. 2011. Nucleolin protein interacts with microprocessor complex to affect biogenesis of microRNAs 15a and 16. J Biol Chem 286 (51): 44095-44103.
30. Richards CD,. 2013. The enigmatic cytokine oncostatin m and roles in disease. ISRN Inflamm 2013: 512103.
31. Schneider HR, Issinger OG,. 1988. Nucleolin (C23), a physiological substrate for casein kinase II. Biochem Biophys Res Commun 156 (3): 1390-1397.
32. Sengupta TK, Bandyopadhyay S, Fernandes DJ, Spicer EK,. 2004. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J Biol Chem 279 (12): 10855-10863.
33. Shyu AB, Greenberg ME, Belasco JG,. 1989. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev 3 (1): 60-72.
34. Singh RA, Sodhi A,. 1998. Cisplatin-treated macrophages produce oncostatin M: Regulation by serine/threonine and protein tyrosine kinases/phosphatases and Ca2+/calmodulin. Immunol Lett 62 (3): 159-164.
35. Smith DA, Kiba A, Zong A, Witte ON,. 2013. Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues. Mol Cancer Res 11 (10): 1159-1165.
36. Tajrishi MM, Tuteja R, Tuteja N,. 2011. Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol 4 (3): 267-275.
37. Tanaka M, Miyajima A,. 2003. Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149: 39-52.
38. Wahl AF, Wallace PM,. 2001. Oncostatin M in the anti-inflammatory response. Ann Rheum Dis 60 (Suppl 3): iii75-iii80.
39. Warrener P, Petryshyn R,. 1991. Phosphorylation and proteolytic degradation of nucleolin from 3T3-F442A cells. Biochem Biophys Res Commun 180 (2): 716-723.
40. Westmark CJ, Malter JS,. 2001. Up-regulation of nucleolinmRNA and protein in peripheral blood mononuclear cells by extracellular-regulated kinase. J Biol Chem 27 (62): 1119-1126.
41. Wu X, Brewer G,. 2012. The regulation of mRNA stability in mammalian cells: 2.0. Gene 500 (1): 10-21.
42. Xu Y, Zhang F, Qin L, Miao J, Sheng W, Xie Y, Xu X, Yang J, Qian H,. 2014. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy. Melanoma Res 24 (1): 20-31.
43. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ,. 1986. OncostatinM: A growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83 (24): 9739-9743.
44. Zhang J, Tsaprailis G, Bowden GT,. 2008. Nucleolin Stabilizes Bcl-XL Messenger RNA in Response to UVA Irradiation. Cancer Res 68: 1046-1054.